Related Experiment Video

Updated: Dec 22, 2025

Using a Combination of Indirect Calorimetry, Infrared Thermography, and Blood Glucose Levels to Measure Brown Adipose Tissue Thermogenesis in Humans
04:54

Using a Combination of Indirect Calorimetry, Infrared Thermography, and Blood Glucose Levels to Measure Brown Adipose Tissue Thermogenesis in Humans

Published on: June 2, 2023

1.8K

Effect of green cardamom on lipoproteins, glycemic control and anthropometric parameters: A meta-analysis of

Omid Asbaghi1, Elham Eslampour1, Željko Reiner2

  • 1Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.

Clinical Nutrition ESPEN
|May 4, 2020
PubMed

Insights

Green cardamom supplementation significantly reduced triglyceride levels. However, it did not impact other lipid profiles, glucose levels, or body weight, though it increased BMI in some studies.

Area of Science:

  • Nutritional Science
  • Metabolic Health
  • Evidence-Based Medicine

Background:

  • Cardamom is a spice used in traditional medicine.
  • Its effects on metabolic markers are not fully understood.
  • Systematic reviews are needed to consolidate evidence.

Purpose of the Study:

  • To systematically review and meta-analyze randomized controlled trials (RCTs) on green cardamom's effects.
  • To evaluate impacts on lipoproteins, glycemic control, and anthropometric parameters.
  • To compare outcomes in healthy individuals and those with diseases.

Main Methods:

  • Systematic search of EMBASE, Scopus, PubMed, Cochrane Library, Web of Science.
  • Inclusion of RCTs with data on serum lipoproteins, glycemic control, and anthropometric parameters.
  • Random-effects model used for data pooling; heterogeneity assessed with Cochrane's Q and I² statistics.

Main Results:

  • Seven trials were included in the meta-analysis.
  • Green cardamom significantly reduced triglyceride levels compared to controls.
  • No significant effects observed on total cholesterol, LDL-C, HDL-C, fasting plasma glucose, or body weight.

Conclusions:

  • Green cardamom intake significantly lowers triglyceride levels.
  • This reduction may indirectly improve metabolic disorder symptoms.
  • Further research on cardamom's role in metabolic health is warranted.
Abstract

Keywords:
Glycemic controlGreen cardamomMeta-analysisSerum lipoproteinsTriglycerides

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.6K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

334

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
457
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
180
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
504
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
527